Search results
Results from the WOW.Com Content Network
The Regeneron International Science and Engineering Fair (ISEF) is an annual science fair in the United States. [1] It is owned and administered by the Society for Science, [2] a 501(c)(3) non-profit organization based in Washington, D.C. [3] Each May, more than 1800 students from roughly 75 countries and territories compete in the fair for scholarships, tuition grants, internships, scientific ...
The Regeneron Science Talent Search, known for its first 57 years [1] as the Westinghouse Science Talent Search, and then as the Intel Science Talent Search (Intel STS) from 1998 through 2016, [2] is a research-based science competition in the United States for high school seniors.
The Regeneron International Science and Engineering Fair, or ISEF, is the largest high school STEM competition in the world. • Saathvik Kannan received one of two Regeneron Young Scientist ...
The Intel Foundation Achievement Awards are US$5,000 scholarships presented to high school students in recognition of their achievements in the scientific disciplines. Up to 15 are awarded, on selection by a panel of judges, each year at the Intel International Science and Engineering Fair (ISEF).
Drug companies Regeneron Pharmaceuticals, Inc (REGN) and Sanofi announced that the U.S. Food and Drug Administration approved its Dupixent drug for the treatment of dermatitis in children.The ...
The Siemens Competition was a science competition for US high school students funded by the Siemens Foundation, which was administered by the College Board from 1999-2013 and by Discovery Education from 2014–2017. [1]
Regeneron (REGN) and Sanofi's (SNY) Dupixent receives label expansion in the European Union for severe asthma with type 2 inflammation in children aged between 6 years and 11 years.
Sanofi, in order to get out of its commitment, paid Regeneron $50 million and ceded the rights back to Regeneron. [2] The drug was a blockbuster generating $838 million in its first full year and sales increased 55% to $1.3 billion in 2013 [3] making Schleifer a billionaire. [2] In 2014 Eylea grossed $1.735 billion. [4]